Aura Biosciences, Inc.
AURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501796
No open-market purchases or sales by Aura Biosciences, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $677.2M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Aura Biosciences, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +12 vs. Q1 2025
- Shares held
- 50.6M
- +10.8M (+27.0%) vs. Q1 2025
- Total value
- $316.9M
- +$85.3M (+36.8%) vs. Q1 2025
- New holders
- 26
- 32 more added
- Sold out
- 14
- 30 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 146 | $677.2M |
| Q1 2026 | 126 | $340.3M |
| Q4 2025 | 117 | $273.8M |
| Q3 2025 | 106 | $319.2M |
| Q2 2025 | 105 | $316.9M |
| Q1 2025 | 94 | $231.5M |
| Q4 2024 | 94 | $324.3M |
| Q3 2024 | 81 | $329.2M |
| Q2 2024 | 75 | $300.4M |
| Q1 2024 | 78 | $307.1M |
| Q4 2023 | 72 | $327.8M |
| Q3 2023 | 64 | $254.4M |
| Q2 2023 | 59 | $334.4M |
| Q1 2023 | 57 | $232.6M |
| Q4 2022 | 49 | $250.0M |
| Q3 2022 | 43 | $295.7M |
| Q2 2022 | 44 | $223.8M |
| Q1 2022 | 34 | $298.8M |
| Q4 2021 | 32 | $220.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Aura Biosciences, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 4,372,884 | $27.4M | 1.03% | +1,640,998+60.1% | Added |
| Long Focus Capital Management, LLC | 4,619,582 | $28.9M | 1.87% | +1,300,000+39.2% | Added |
| Adage Capital Partners GP, L.L.C. | 4,881,125 | $30.6M | 0.05% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 5,100,000 | $31.9M | 1.28% | +5,100,000 | New |
| Matrix Capital Management Company, LP | 6,922,870 | $43.3M | 19.45% | 00.0% | Unchanged |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −151,108−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −38,604−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −37,156−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −31,560−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −23,449−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −22,722−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −16,895−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −13,198−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −10,292−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −10,157−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |